Novavax (NVAX) Stock Surges YTD as COVID Vaccine Advances Well

Upon approval and successful commercialization, Novavax’s (NVAX) COVID-19 vaccine should reap huge revenues. The company’s other pipeline candidates a…

Leave a Reply

Your email address will not be published. Required fields are marked *